Cardinal Health shares are in focus after the company posted a 28% increase in non-GAAP diluted EPS to $3.26 and raised its fiscal year guidance following a solid $67.5 billion revenue performance in Q1.
First quarter fiscal 2027 revenue rose 5% to $67.5 billion, non-GAAP operating earnings rose 17% to $1.0 billion and non-GAAP diluted EPS rose 28% to $3.26. The company also raised its fiscal year outlook, a guidance change that typically lifts the stock. No offsetting negative figure appears in the release.
GAAP diluted EPS was $2.38, up 27%, and non-GAAP diluted EPS was $3.26, up 28%, for the first quarter of fiscal year 2027.
Yes, the company raised its fiscal year outlook alongside the first quarter results.
Cardinal Health reported strong first-quarter fiscal 2027 results, with revenue climbing 5% to $67.5 billion. The company saw significant bottom-line growth, as non-GAAP diluted EPS surged 28% to $3.26, prompting management to raise its full-year financial outlook.
Cardinal Health reported GAAP diluted EPS of $2.38 and non-GAAP diluted EPS of $3.26 for the first quarter of fiscal year 2027.
Yes, the company raised its fiscal year outlook following the release of its first-quarter financial results.